Differential solubility of prions is associated in manifold phenotypes

[1]  J. Hauw,et al.  Correction: Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains , 2008, PLoS ONE.

[2]  J. Hauw,et al.  Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains , 2008, PloS one.

[3]  J. Manson,et al.  Host PrP Glycosylation: A Major Factor Determining the Outcome of Prion Infection , 2008, PLoS biology.

[4]  I. Izquierdo,et al.  Physiology of the prion protein. , 2008, Physiological reviews.

[5]  H. Karch,et al.  Regional and phenotype heterogeneity of cellular prion proteins in the human brain , 2007, The European journal of neuroscience.

[6]  H. Karch,et al.  Binding of N‐ and C‐terminal anti‐prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse , 2007, The FEBS journal.

[7]  J. Grassi,et al.  Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting , 2007, Neurochemistry International.

[8]  J. Launay,et al.  Cellular Prion Protein Signaling in Serotonergic Neuronal Cells , 2007, Annals of the New York Academy of Sciences.

[9]  J. McGeehan,et al.  Insoluble Aggregates and Protease-resistant Conformers of Prion Protein in Uninfected Human Brains* , 2006, Journal of Biological Chemistry.

[10]  C. Fonta,et al.  Truncated PrPc in mammalian brain: interspecies variation and location in membrane rafts , 2006, Biological chemistry.

[11]  H. Kretzschmar,et al.  Prion protein induced signaling cascades in monocytes. , 2006, Biochemical and biophysical research communications.

[12]  J. Langeveld,et al.  Immunopathology and Infectious Diseases Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob Disease , 2005 .

[13]  A. Aguzzi,et al.  Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease , 2005, The Lancet Neurology.

[14]  S. Prusiner,et al.  Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro , 2005, Journal of neurochemistry.

[15]  J. Ironside,et al.  Prion protein heterogeneity in sporadic but not variant Creutzfeldt–Jakob disease: U.K. cases 1991–2002 , 2004, Annals of neurology.

[16]  A. Buschmann,et al.  Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests. , 2004, Journal of virological methods.

[17]  F. Tagliavini,et al.  Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  V. Mutel,et al.  NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Collinge,et al.  Regional heterogeneity of cellular prion protein isoforms in the mouse brain. , 2003, Brain : a journal of neurology.

[20]  P. Sarradin,et al.  Cases of scrapie with unusual features in Norway and designation of a new type, Nor98 , 2003, Veterinary Record.

[21]  H. Budka,et al.  Molecular classification of sporadic Creutzfeldt-Jakob disease. , 2003, Brain : a journal of neurology.

[22]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[23]  I. Vorberg,et al.  Molecular Basis of Scrapie Strain Glycoform Variation* , 2002, The Journal of Biological Chemistry.

[24]  C. Soto,et al.  Cyclic amplification of protein misfolding: application to prion-related disorders and beyond , 2002, Trends in Neurosciences.

[25]  Tong Liu,et al.  Heterogeneity of normal prion protein in two‐dimensional immunoblot: presence of various glycosylated and truncated forms , 2002, Journal of neurochemistry.

[26]  G. Edelman,et al.  Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. , 2001, Journal of molecular biology.

[27]  D. Dormont,et al.  Identification of interaction domains of the prion protein with its 37‐kDa/67‐kDa laminin receptor , 2001, The EMBO journal.

[28]  B. Strooper,et al.  The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. , 2001, The Journal of biological chemistry.

[29]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[30]  J. Collinge,et al.  Location and properties of metal-binding sites on the human prion protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[32]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Buschmann,et al.  Characterization of BSE and scrapie strains/isolates. , 2000, Archives of virology. Supplementum.

[34]  D. Dormont,et al.  New insight into abnormal prion protein using monoclonal antibodies. , 1999, Biochemical and biophysical research communications.

[35]  S. Prusiner,et al.  Glycosylation differences between the normal and pathogenic prion protein isoforms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  V. Daggett,et al.  PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. , 1999, Journal of neuropathology and experimental neurology.

[37]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[38]  B. Ghetti,et al.  Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. , 1998, The American journal of pathology.

[39]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[40]  M. Groschup,et al.  Molecular analysis of bovine spongiform encephalopathy and scrapie strain variation. , 1998, The Journal of infectious diseases.

[41]  P E Wright,et al.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Cohen,et al.  Selective Neuronal Targeting in Prion Disease , 1997, Neuron.

[43]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.

[44]  A. Chong,et al.  Biochemical typing of scrapie strains , 1997, Nature.

[45]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[46]  D. Teplow,et al.  Truncated Forms of the Human Prion Protein in Normal Brain and in Prion Diseases (*) , 1995, The Journal of Biological Chemistry.

[47]  B. Caughey.  Scrapie associated PrP accumulation and its prevention: insights from cell culture. , 1993, British medical bulletin.

[48]  N. Cashman,et al.  Nearly ubiquitous tissue distribution of the scrapie agent precursor protein , 1992, Neurology.

[49]  S. Prusiner,et al.  Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. , 1989, Biochemistry.

[50]  S. Prusiner,et al.  Scrapie prion proteins are synthesized in neurons. , 1986, The American journal of pathology.